159098-82-5

Upstream product

• 133747-81-6 (+/-)-1-(4-tert-butylphenyl)-2-oxo-pyrrolidine-4-carboxylic acid 
• 158898-09-0 (S)-N-[α-methyl(4-methyl)benzyl]-(S)-[1-(4-tert-butylphenyl)-2-oxo-pyrrolidine-4-yl]carboxamide 

Downstream Products

• 155730-92-0 (S)-(+)-4-{[1-(4-tert-butylphenyl)-2-oxo-pyrrolidin-4-yl]methoxy}benzoic acid 
• 155730-90-8 (S)-(+)-methyl 4-{[1-(4-tert-butylphenyl)-2-oxo-pyrrolidin-4-yl]methoxy}benzoate 
• 155730-88-4 (S)-(+)-[1-(4-tert-butylphenyl)-2-oxo-pyrrolidine-4-yl]methyl methanesulfonate 
• 155730-85-1 (S)-(-)-1-(4-tert-butylphenyl)-4-hydroxymethyl-2-oxo-pyrrolidine 

Relevant academic research and scientific papers

Synthesis of the optical isomers of 4-[1-(4-tert-butylphenyl)-2- oxopyrrolidine-4-yl]methyloxybenzoic acid (S-2) and their biological evaluation as antilipidemic agent

The enantiomers of (±)-4-[1-(4-tert-butylphenyl)-2-oxo-pyrrolidine-4- yl]methyloxybenzoic acid (S-2), a new antilipidemic agent having dual action on the plasma triglyceride (TG) and cholesterol (Cho) lowering effects, were prepared via separation by Chir